SCHEMBL4247225

SCHEMBL4247225

NCCC(=O)CNC(Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 7/20 0.40
CPB1 P15086 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4247228 1.00 CPB2 (0.40) CPB2CPB1
SCHEMBL14344575 0.84 CPB2 (0.38) CPB2CPB1
SCHEMBL3839540 0.84 CPB2 (0.55) CPB2CPB1
SCHEMBL3845157 0.84 CPB2 (0.55) CPB2CPB1
SCHEMBL365025 0.84 CPB2 (0.37) CPB2CPB1
SCHEMBL10777853 0.82 CPB2 (0.40) CPB2CPB1
SCHEMBL7074055 0.82 CPB2 (0.40) CPB2CPB1
Carnosine SCHEMBL33769 0.82 ITGB3 (0.41) CPB2CPB1
Carnosine SCHEMBL3904964 0.82 ITGB3 (0.41) CPB2CPB1
Carnosine SCHEMBL1161010 0.82 ITGB3 (0.41) CPB2CPB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060182652-A1 Methods for sterilizing biological materials using dipeptide stabilizers CLEARANT INC. 2006-08-17 US claimed
CN-109952372-A Obtain the new method of the composition based on viral vectors effective for vaccine inoculation or gene therapy 白血球保健股份有限公司 2019-06-28 CN disclosed
CN-105636609-A A NOVEL METHOD FOR THE PRODUCTION OF STABILE VACCINES LEUKOCARE AG 2016-06-01 CN disclosed
US-20090214382-A1 Methods of sterilizing biological mixtures using alpha-keto acids CLEARANT, INC. 2009-08-27 US disclosed
US-20080080998-A1 Propylene glycol, dimethyl sulfoxide, trehalose and mannitol and gamma radiation; reduce active biological contaminants or pathogens in bone; reduce post-implantation complications, inflammation, immune rejection reactions, calcification CLEARANT, INC. 2008-04-03 US disclosed
US-20060182652-A1 Methods for sterilizing biological materials using dipeptide stabilizers CLEARANT INC. 2006-08-17 US disclosed
US-6979829-B2 Devices and methods for determining the amount of energy absorbed during irradiation CLEARANT INC. (US) 2005-12-27 US disclosed
US-6908591-B2 Methods for sterilizing biological materials by irradiation over a temperature gradient CLEARANT, INC. (US) 2005-06-21 US disclosed
EP-1539254-A2 METHODS FOR STERILIZING BIOLOGICAL MATERIALS BY IRRADIATION OVER A TEMPERATURE GRADIENT Clearant, Inc. (US) 2005-06-15 EP disclosed
US-20050106728-A1 Methods of sterilizing biological mixtures using stabilizer mixtures CLEARANT INC. 2005-05-19 US disclosed
US-20030124023-A1 Method of sterilizing heart valves CLEARANT, INC. 2003-07-03 US disclosed
WO-2003035238-A2 METHODS FOR COMBATING BIO-TERRORISM CLEARANT, INC. (US) 2003-05-01 WO disclosed
WO-2003030949-A1 METHODS OF STERILIZING BIOLOGICAL MATERIALS CLEARANT INC. (US) 2003-04-17 WO disclosed
WO-2003030948-A1 METHODS FOR STERILIZING BIOLOGICAL MATERIALS USING DIPEPTIDE STABILIZERS CLEARANT, INC. (US) 2003-04-17 WO disclosed
WO-2003026704-A1 METHODS OF STERILIZING BIOLOGICAL MIXTURES USING STABILIZER MIXTURES CLEARANT, INC. (US) 2003-04-03 WO disclosed
US-20030064000-A1 Methods of sterilizing biological mixtures using stabilizer mixtures CLEARANT, INC. 2003-04-03 US disclosed
WO-2003026705-A1 METHODS FOR STERILIZING BIOLOGICAL MATERIALS USING FLAVONOID/FLAVONOL STABILIZERS CLEARANT, INC. (US) 2003-04-03 WO disclosed
US-20030059338-A1 Methods for sterilizing biological materials using flavonoid/flavonol stabilizers CLEARANT, INC. 2003-03-27 US disclosed
US-20030031584-A1 Methods for sterilizing biological materials using dipeptide stabilizers CLEARANT, INC. 2003-02-13 US disclosed
US-20030012687-A1 Methods of sterilizing biological materials CLEARANT, INC. 2003-01-16 US disclosed